{
  "spec_version": "3",
  "endpoint": "decisions",
  "stock_code": "4507",
  "company_name": "塩野義製薬",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4507/",
  "api_url": "/api/4507/decisions.json",
  "updated": "2026-09-05",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4507/",
  "count": 4,
  "description": "Index of this company's management decisions. One decision = one endpoint: follow api_url for the full dossier (background, the decision itself, outcome, quoted primary sources and references). Entries flagged report_published: false expose everything except that narrative.",
  "decisions": [
    {
      "slug": "original-drug-research-1961",
      "url": "/tse/4507/decisions/original-drug-research-1961/",
      "api_url": "/api/4507/decisions/original-drug-research-1961.json",
      "year": 1961,
      "month": null,
      "type": "transformation",
      "tags": [
        "st-tech",
        "bm-channel"
      ],
      "title": "導入品依存からの転換と、独創品開発に向けた新研究所の建設",
      "subtitle": "「人真似の歴史」と自ら断じた塩野孝太郎氏は、売上の拡大を止めてまで何に投じたか",
      "status": "implemented"
    },
    {
      "slug": "sciele-acquisition-2008",
      "url": "/tse/4507/decisions/sciele-acquisition-2008/",
      "api_url": "/api/4507/decisions/sciele-acquisition-2008.json",
      "year": 2008,
      "month": null,
      "type": "acquisition",
      "tags": [
        "ma-crossborder-out",
        "gl-entry"
      ],
      "title": "米サイエル・ファーマをTOBで完全子会社化し、初の本格的な米国販売基盤を築く",
      "subtitle": "社長就任直後の手代木功氏は、約14億ドルを投じてなぜ自前の海外販売網を丸ごと買ったか",
      "status": "implemented",
      "report_published": false
    },
    {
      "slug": "viiv-hiv-royalty-2012",
      "url": "/tse/4507/decisions/viiv-hiv-royalty-2012/",
      "api_url": "/api/4507/decisions/viiv-hiv-royalty-2012.json",
      "year": 2012,
      "month": null,
      "type": "alliance",
      "tags": [
        "bm-model-shift",
        "cp-crossholding",
        "pf-focus"
      ],
      "title": "HIV合弁持分の英ViiV Healthcareへの移転と、ViiV株式10%の取得",
      "subtitle": "米国の販売網を買った4年後、手代木功氏はなぜ最大の新薬を自前で売らない形に組み替えたか",
      "status": "implemented",
      "report_published": false
    },
    {
      "slug": "zocova-emergency-approval-2022",
      "url": "/tse/4507/decisions/zocova-emergency-approval-2022/",
      "api_url": "/api/4507/decisions/zocova-emergency-approval-2022.json",
      "year": 2022,
      "month": null,
      "type": "strategy",
      "tags": [
        "tr-crisis",
        "st-tech"
      ],
      "title": "新型コロナ経口薬ゾコーバの緊急承認制度による承認取得と、承認前からの生産着手",
      "subtitle": "ワクチンで欧米勢を追わないと決めた手代木功氏は、有効性の評価が割れるなかで何を取りにいったか",
      "status": "implemented",
      "report_published": false
    }
  ],
  "by_type": [
    {
      "key": "acquisition",
      "count": 1,
      "url": "/api/4507/decisions/by-type/acquisition.json"
    },
    {
      "key": "alliance",
      "count": 1,
      "url": "/api/4507/decisions/by-type/alliance.json"
    },
    {
      "key": "strategy",
      "count": 1,
      "url": "/api/4507/decisions/by-type/strategy.json"
    },
    {
      "key": "transformation",
      "count": 1,
      "url": "/api/4507/decisions/by-type/transformation.json"
    }
  ],
  "by_decade": [
    {
      "key": "1960s",
      "count": 1,
      "url": "/api/4507/decisions/by-decade/1960s.json"
    },
    {
      "key": "2000s",
      "count": 1,
      "url": "/api/4507/decisions/by-decade/2000s.json"
    },
    {
      "key": "2010s",
      "count": 1,
      "url": "/api/4507/decisions/by-decade/2010s.json"
    },
    {
      "key": "2020s",
      "count": 1,
      "url": "/api/4507/decisions/by-decade/2020s.json"
    }
  ]
}